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Sir,
Recently a significantly increased risk for acoustic neuroma was
reported for 10 years or more use of mobile phone on the same
side of the head as the tumour developed (Schoemaker et al, 2005).
Thus, our previous reports of such an association were confirmed
(Hardell et al, 2002, 2003a,b, 2005a). However, the authors write
that there is no substantial risk in the first decade after starting of
mobile phone use, a statement that has echoed in news media
as the main result and has little significance in long-term
carcinogenesis.
We are surprised that the authors claim that our first study
(Hardell et al, 2002, 2003a,b) has been ‘heavily criticised for
methodological limitations’. They give reference to five short
comments or reports, two published in 2000 and 2001 (Rothman,
2000, 2001), thus even before our publication! The report by Boice
and McLaughlin (2002) has never been published in a prereview
journal and they are employed at an institute that has been linked
to Motorola (Hardell, 2004). The other two references include
authors of the Interphone study, thus merely themselves. No
information is given in the paper (Schoemaker et al, 2005)
regarding our ‘methodological limitations’, so we compare
standard epidemiological methods in the Interphone study and
our studies (same methods were used in our two studies).
Controls were in the Interphone study recruited from general
practioners’ lists (UK), whereas all controls in the Hardell et al
studies were selected from the population register.
Recall and observation bias was probable in the Interphone
study since interviews were computer based and conducted at the
subject’s home, the hospital or another place. Thus, the situation
might have been stressful for the interviewed person; the
interviewer knew if it was a case or a control that was interviewed,
the interview place was not standardised and a large number of
interviewers must have been involved (numbers not presented).
Furthermore, we are not told how controls were selected living in
vast areas such as Northern Sweden; only from the largest cities? At
least in the Norwegian part of the study some of the controls were
recruited by phone, thus giving potential for selection bias as to
use of cellular telephones. Did the interviewers travel long
distances or were controls with uncomfortable addresses dis-
regarded?
The study group had knowledge during the full process until
statistical analysis if it was a case or a control. In contrast, the
Hardell et al studies used standard methods with questionnaires
sent to the homes of cases and controls and if necessary
supplemented over the phone. Assessment of exposure was
performed blinded as to case or control status, as well as coding
and registration of exposure for statistical analysis in our studies.
As we have previously commented (Hardell and Hansson Mild
2005b) on the Swedish part (Lo ¨nn et al, 2004) of this Interphone
study the numbers in the different tables are not easy to follow.
Schoemaker et al (2005) present in Table 2 numbers of subjects
with X10 years lifetime use of mobile phone; 31 cases and 131
controls. However, in Table 4 analysing mobile phone use and
laterality of tumour the corresponding numbers are 35 cases and
145 controls. Moreover, numbers of ‘unexposed’ are not consistent
in these two tables.
We assessed also use of cordless phones in contrast to the
Interphone study. As we have discussed elsewhere (Hardell et al,
2006), such microwave exposure should also be included in this
type of studies. As reference category we used subjects with no
report of use of cellular or cordless phones. However, in contrast
to us the Interphone study had no constant unexposed group for
mobile phone use and the ‘unexposed’ category would furthermore
include cordless phone users, thus diluting the risk towards unity.
The authors stated that the studies were partly financed by the
telecom industry. According to IARC the funding from industry
was 3.5 million Euros, and from the European Union, 3.85 million
Euros (E Cardis, personal communication). The contract
stipulated that the industry has the right to be informed about
the results a maximum of 7 days before the publication (IARC,
2005).
Receiving grants from industry is by the International
Committee of Medical Journal Editor regarded as ‘the most
important conflicts of interest’. In a review of health studies on
environmental tobacco smoke the rate ratio of a paper with at least
one author with industry associations reaching an industry
favourable conclusion was 3.2, 95% CI 1.4–7.5 (Garne et al,
2005). Could this explain the almost excuse of the own results, see
last paragraph in the paper, and the scientifically unfounded
criticism of our studies by the Interphone study authors? Published online 28 March 2006
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